• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌患者长期进入腹膜腔。

Long-term access to the peritoneal cavity in ovarian cancer patients.

作者信息

Rubin S C, Hoskins W J, Markman M, Hakes T, Lewis J L

机构信息

Department of Surgery, Memorial Sloan-Kettering Cancer Center.

出版信息

Gynecol Oncol. 1989 Apr;33(1):46-8. doi: 10.1016/0090-8258(89)90601-x.

DOI:10.1016/0090-8258(89)90601-x
PMID:2703166
Abstract

One hundred thirty-six totally implanted peritoneal catheter systems were placed in 130 patients. No complications occurred at catheter placement. A total of 629 courses of intraperitoneal therapy were administered. The average catheter has remained in place for 4.5 months (range 1-19 months). Seven catheters (5.1%) were removed for infection. An additional 7 catheters were removed because of blockage, for a total removal rate due to complications of 10.2%. Catheters were not used for drainage of the peritoneal cavity. The totally implanted peritoneal catheter system provides a reliable means for long-term access to the peritoneal cavity in patients with ovarian cancer.

摘要

130例患者共置入136套完全植入式腹膜导管系统。置管时未发生并发症。共进行了629疗程的腹腔内治疗。导管平均留置时间为4.5个月(范围1 - 19个月)。7根导管(5.1%)因感染被拔除。另有7根导管因堵塞被拔除,并发症导致的总拔除率为10.2%。导管未用于腹腔引流。完全植入式腹膜导管系统为卵巢癌患者提供了一种可靠的长期进入腹腔的途径。

相似文献

1
Long-term access to the peritoneal cavity in ovarian cancer patients.卵巢癌患者长期进入腹膜腔。
Gynecol Oncol. 1989 Apr;33(1):46-8. doi: 10.1016/0090-8258(89)90601-x.
2
It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy catheters.它不再仅仅用于腹腔镜检查:介入放射科医生在超声和荧光透视引导下使用充气来进行经皮放置腹腔内化疗导管。
Gynecol Oncol. 2011 Nov;123(2):342-5. doi: 10.1016/j.ygyno.2011.07.031. Epub 2011 Aug 15.
3
A ten-year single-centre experience in children on chronic peritoneal dialysis--significance of percutaneous placement of peritoneal dialysis catheters.儿童慢性腹膜透析十年单中心经验——腹膜透析导管经皮置入的意义
Nephrol Dial Transplant. 2007 Jul;22(7):2045-51. doi: 10.1093/ndt/gfm150. Epub 2007 Apr 16.
4
Complications associated with intraperitoneal chemotherapy catheters.与腹腔内化疗导管相关的并发症。
Gynecol Oncol. 2001 Apr;81(1):77-81. doi: 10.1006/gyno.2000.6108.
5
The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.格罗雄导管作为一种用于治疗卵巢癌患者的腹腔内通路装置。
Gynecol Oncol. 1993 Sep;50(3):291-3. doi: 10.1006/gyno.1993.1213.
6
[Complications following implantatation of a Tenckhoff catheter for the intraperitoneal administration of chemotherapeutic agents].[用于腹腔内化疗药物给药的Tenckhoff导管植入术后并发症]
Ned Tijdschr Geneeskd. 1987 Feb 21;131(8):323-6.
7
Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter.使用Tenckhoff导管进行腹腔内化疗的技术考量
Surg Gynecol Obstet. 1982 Jun;154(6):858-62.
8
[Evaluation of surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].[卵巢癌腹腔内化疗相关手术并发症的评估]
Ginekol Pol. 2002 Nov;73(11):1103-8.
9
[Surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].[卵巢癌腹腔内化疗相关的手术并发症]
Ginekol Pol. 2003 Sep;74(9):817-23.
10
Intraperitoneal therapy administered through a Groshong catheter.通过Groshong导管进行腹腔内治疗。
Gynecol Oncol. 1994 Jun;53(3):320-5. doi: 10.1006/gyno.1994.1141.